Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

High Ferritin and Low Glycosylated Ferritin May Also Be a Marker of Excessive Macrophage Activation

OLIVIER LAMBOTTE, PATRICE CACOUB, NATHALIE COSTEDOAT, GISELE Le MOEL, ZAHIR AMOURA, and JEAN-CHARLES PIETTE

ABSTRACT.

Objective.
A high serum ferritin concentration with a low percentage of glycosylated ferritin (< 20%) have been reported to be a specific marker of active adult Still's disease (ASD). However, high ferritin levels are found during hemophagocytosis syndrome (HS). We investigated the ferritin level and the percentage of glycosylation in a HS series of various causes.

Methods. Diagnosis of HS was confirmed by erythrophagocytosis pictures on a bone marrow cytology or biopsy in all patients. Serum ferritin concentration was determined on a heterogenous immunoassay module. Glycosylated ferritin was separated using concanavalin A (Con-A) sepharose 4B chromatography. The nonglycosylated ferritin unbound to Con-A was recovered in the supernatant and quantified with the same procedure. Percentages of glycosylated ferritin less than 20% are considered to be usual in ASD, between 20 and 40% usual in inflammatory syndrome, and between 50 and 80% normal.

Results. In all cases tested during the acute phase of the disease, ferritin blood level was high and the percentage of glycosylated ferritin was low, less than 20%.

Conclusion. The combination of high ferritin level and low percentage of glycosylation may be a marker of excessive macrophage activation. (J Rheumatol 2003;30:1027-8)

Key Indexing Terms:

FERRITIN
GLYCOSYLATED FERRITIN
MACROPHAGE ACTIVATION
HEMOPHAGOCYTOSIS SYNDROME


From the Department of Internal Medicine, Groupe Hospitalier Pitié Salpêtrière; and Department of Biochemistry, Hôpital Bichat Claude Bernard, Paris, France.

O. Lambotte, MD; N. Costedoat, MD; Z. Amoura, MD; J-C. Piette, MD; P. Cacoub, MD, Department of Internal Medicine, Hospitalier Pitié Salpêtrière; G. Le Moel, MD, Department of Biochemistry, Hôpital Bichat Claude Bernard.

Address reprint requests to Pr. P. Cacoub, Service de Médecine Interne, Groupe Hospitalier Pitié Salpêtrière, 47-83 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France. E-mail: patrice.cacoub@psl.ap-hop-paris.fr

Submitted July 22, 2002; revision accepted October 28, 2002.




Return to May 2003 Table of Contents



© 2003. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.